Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1954 1
1959 1
1965 1
1966 1
1973 1
1978 4
1979 1
1980 1
1982 1
1983 2
1984 1
2010 1
2013 1
2014 5
2015 4
2016 5
2017 5
2018 6
2019 12
2020 30
2021 28
2022 16
2023 4

Text availability

Article attribute

Article type

Publication date

Search Results

111 results

Results by year

Filters applied: . Clear all
Page 1
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.
González-Martín A, Pothuri B, Vergote I, DePont Christensen R, Graybill W, Mirza MR, McCormick C, Lorusso D, Hoskins P, Freyer G, Baumann K, Jardon K, Redondo A, Moore RG, Vulsteke C, O'Cearbhaill RE, Lund B, Backes F, Barretina-Ginesta P, Haggerty AF, Rubio-Pérez MJ, Shahin MS, Mangili G, Bradley WH, Bruchim I, Sun K, Malinowska IA, Li Y, Gupta D, Monk BJ; PRIMA/ENGOT-OV26/GOG-3012 Investigators. González-Martín A, et al. Among authors: haggerty af. N Engl J Med. 2019 Dec 19;381(25):2391-2402. doi: 10.1056/NEJMoa1910962. Epub 2019 Sep 28. N Engl J Med. 2019. PMID: 31562799 Clinical Trial.
Combination ATR and PARP Inhibitor (CAPRI): A phase 2 study of ceralasertib plus olaparib in patients with recurrent, platinum-resistant epithelial ovarian cancer.
Shah PD, Wethington SL, Pagan C, Latif N, Tanyi J, Martin LP, Morgan M, Burger RA, Haggerty A, Zarrin H, Rodriguez D, Domchek S, Drapkin R, Shih IM, Smith SA, Dean E, Gaillard S, Armstrong D, Torigian DA, Hwang WT, Giuntoli R, Simpkins F. Shah PD, et al. Among authors: haggerty a. Gynecol Oncol. 2021 Nov;163(2):246-253. doi: 10.1016/j.ygyno.2021.08.024. Epub 2021 Oct 5. Gynecol Oncol. 2021. PMID: 34620496 Free PMC article. Clinical Trial.
Validation of a tablet-based assessment of auditory sensitivity for researchers.
Wiseman K, Slotkin J, Spratford M, Haggerty A, Heusinkvelt M, Weintraub S, Gershon R, McCreery R. Wiseman K, et al. Among authors: haggerty a. Behav Res Methods. 2022 Aug 12:10.3758/s13428-022-01933-1. doi: 10.3758/s13428-022-01933-1. Online ahead of print. Behav Res Methods. 2022. PMID: 35962308
Biomaterials for spinal cord repair.
Haggerty AE, Oudega M. Haggerty AE, et al. Neurosci Bull. 2013 Aug;29(4):445-59. doi: 10.1007/s12264-013-1362-7. Epub 2013 Jul 18. Neurosci Bull. 2013. PMID: 23864367 Free PMC article. Review.
Lymphadenectomy for early-stage mucinous ovarian carcinoma.
Heyward QD, Nasioudis D, Cory L, Haggerty AF, Ko EM, Latif N. Heyward QD, et al. Among authors: haggerty af. Int J Gynecol Cancer. 2021 Jan;31(1):104-109. doi: 10.1136/ijgc-2020-001817. Epub 2020 Nov 26. Int J Gynecol Cancer. 2021. PMID: 33243777
A Machine Learning Approach to Management of Heart Failure Populations.
Jing L, Ulloa Cerna AE, Good CW, Sauers NM, Schneider G, Hartzel DN, Leader JB, Kirchner HL, Hu Y, Riviello DM, Stough JV, Gazes S, Haggerty A, Raghunath S, Carry BJ, Haggerty CM, Fornwalt BK. Jing L, et al. Among authors: haggerty a. JACC Heart Fail. 2020 Jul;8(7):578-587. doi: 10.1016/j.jchf.2020.01.012. Epub 2020 May 6. JACC Heart Fail. 2020. PMID: 32387064 Free article.
111 results